Skip to main content
. 2021 Jun 17;11:684629. doi: 10.3389/fonc.2021.684629

Table 1.

Study characteristics of 18F-choline PET/CT.

Author Publication Year Country Design Patients Mean age/Range PSA (ng/mL) Scancer Modality Ligand Mean dose Reference standard
Pelosi 2008 Italy R 56 67.9 ± 7 4.59 ± 7.87 Discovery ST unit, GE 18F-choline 185–259 MBq Multiple
Kwee 2012 US P 50 69.0 ± 8.9 3.2 (0.2–18.2) Philips Gemini TF-64 18F-fluorocholine 2.6 MBq/kg Multiple
Panebianco 2012 Italy P 84 56–72 1.63 Discovery ST, GE 18F-choline 185-259 MBq Multiple
Schillaci 2012 Italy P 49 70. 9 ± 7 4.13 ± 4.56 Discovery ST, GE 18F-choline 370 MBq Biopsy
Detti 2013 Italy R 170 —— 3.5 ± 8.8 PET/CT Philips TOF 18F-fluorocholine 3.7 MBq/kg Follow-up
Marzola 2013 Italy R 233 69.4 ± 6.5 7.4 ± 13.6 Discovery STE 18F-fluorocholine 3 MBq/kg
Piccardo 2014 Italy P 21 77.2 ± 5.1 5.8 ± 3.4 Discovery ST, GE 18F-choline 3MBq/kg Multiple
Morigi 2015 Australia P 38 68(54–81) 1.72 ± 2.54 Philips Ingenuity TF 64 18F-fluorocholine 3.5 MBq/kg Biopsy
Rodado-Marina 2015 Spain R 233 68 ± 7.1 5.3 ± 8.7 GE and Siemens equipments 18F-fluorocholine 4 MBq/kg Multiple
Cimitan 2015 Italy R 1,000 69.68 ± 7.67 3.30 GE Discovery LS; Siemens Biograph 16 HT or Biograph mCT; GE Discovery ST8, 18F-choline 3.0–3.5 MBq/kg Multiple
Simone 2015 Italy P 146 68 0.6 (0.43–0.76) Siemens Biograph Hi-Rez 16; 18F-choline 4 MBq/kg Multiple
Emmett 2018 Australia P 91 64 (59–69) 0.42 (0.29–0.93) —— 18F-choline 3.6 MBq/kg Multiple
Giovacchini 2019 Italy R 192 73.2 ± 6.6 9.53 ± 16.70 GE Discovery 710 18F-fluorocholine 3.7 MBq/kg Multiple
Witkowska-Patena 2019 Poland P 40 68.6 ± 6.5 0.75 ± 0.6 GE Discovery 710 18F-fluorocholine 248 ± 35 MBq Multiple
Sánchez 2020 Spain P 108 69 ± 6.7 4.9 ± 5.2 Siemens Biograph mCT 18F-choline 370 MBq Multiple
Zattoni 2020 Italy R 2,798 72 (66.29–77.0) 2.0 (0.1–3.0) —— 18F-choline 2.5-3.7 MBq/kg
de Leiris 2020 France R 115 73.2 (56–89) 9.4 (7.1–18.4) GE Discovery 690 18F-choline 3.7 MBq/kg Multiple

A multiple reference standards including biopsy, other imaging modalities and follow-up.